[go: up one dir, main page]

EE00727U1 - Meetod haruldase muldmetallihendi puhtuse m„„ramiseks - Google Patents

Meetod haruldase muldmetallihendi puhtuse m„„ramiseks

Info

Publication number
EE00727U1
EE00727U1 EEU200700053U EEU200700053U EE00727U1 EE 00727 U1 EE00727 U1 EE 00727U1 EE U200700053 U EEU200700053 U EE U200700053U EE U200700053 U EEU200700053 U EE U200700053U EE 00727 U1 EE00727 U1 EE 00727U1
Authority
EE
Estonia
Prior art keywords
purity
determining
rare earth
earth compound
compound
Prior art date
Application number
EEU200700053U
Other languages
English (en)
Estonian (et)
Inventor
Hallenbeck Donald
Bates Simon
Original Assignee
Shire International Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37057259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE00727(U1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shire International Licensing Bv filed Critical Shire International Licensing Bv
Publication of EE00727U1 publication Critical patent/EE00727U1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
    • G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F17/00—Compounds of rare earth metals
    • C01F17/20—Compounds containing only rare earth metals as the metal element
    • C01F17/247—Carbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Geology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
EEU200700053U 2006-05-05 2007-04-27 Meetod haruldase muldmetallihendi puhtuse m„„ramiseks EE00727U1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06252404A EP1852695B1 (en) 2006-05-05 2006-05-05 Assay for lanthanum hydroxy carbonate

Publications (1)

Publication Number Publication Date
EE00727U1 true EE00727U1 (et) 2008-04-15

Family

ID=37057259

Family Applications (1)

Application Number Title Priority Date Filing Date
EEU200700053U EE00727U1 (et) 2006-05-05 2007-04-27 Meetod haruldase muldmetallihendi puhtuse m„„ramiseks

Country Status (5)

Country Link
EP (1) EP1852695B1 (xx)
AT (2) ATE530896T1 (xx)
DE (1) DE202006016697U1 (xx)
DK (1) DK200600270U4 (xx)
EE (1) EE00727U1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2407993T3 (es) * 2009-05-15 2013-06-17 Natco Pharma Limited Procedimiento para la preparación de carbonato de lantano dihidrato
RU2442143C1 (ru) * 2010-07-19 2012-02-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Способ создания образцовых мер для неразрушающих спектроскопических методов определения концентрации примеси в кристаллах

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
AU751674B2 (en) * 1999-06-21 2002-08-22 Fct-Actech Pty Ltd Method and apparatus for X-ray diffraction analyses
US7130747B1 (en) * 2001-05-31 2006-10-31 Los Alamos National Security, Llc High throughput screening of ligand binding to macromolecules using high resolution powder diffraction
US7469036B2 (en) * 2002-04-19 2008-12-23 Los Alamos National Security, Llc Analysis of macromolecules, ligands and macromolecule-ligand complexes
EP1708723A4 (en) * 2004-07-27 2006-12-20 Shire Pharmaceuticals Inc METHOD FOR TREATING HYPERPHOSPHATEMIA USING LANTHAN HYDROXYCARBONATE

Also Published As

Publication number Publication date
AT9839U1 (de) 2008-04-15
DK200600270U4 (da) 2008-07-25
EP1852695B1 (en) 2011-10-26
AT9839U9 (de) 2008-06-15
DK200600270U1 (da) 2007-08-24
DE202006016697U1 (de) 2007-03-08
ATE530896T1 (de) 2011-11-15
EP1852695A1 (en) 2007-11-07

Similar Documents

Publication Publication Date Title
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
EP2123654A4 (en) pyrazolopyrimidine compound
DK2021486T4 (da) System til fremstilling af bioorganiske forbindelser
EP1985620A4 (en) COMPOUND 10a-AZALIDE
ATE552254T1 (de) Trisubstituierte aminverbindung
IL194354A0 (en) Hetero compound
AP2914A (en) Method for producing 4-oxoquinoline compound
EP2036901A4 (en) C-phenyl 1-thioglucitol compound
EP2011788A4 (en) OXADIAZOLIDINDIONVERBINDUNG
ATE524477T1 (de) Aziridinylepothilonverbindungen
GB0602778D0 (en) Novel compound
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
FI20065363A0 (fi) Erotusmenetelmä
EP2000469A4 (en) ACYLAMINOPIPERIDINVERBINDUNG
ITMI20042238A1 (it) Composti per fluoropolirterei
ZA200808331B (en) Hetero compound
GB0607096D0 (en) Compound
ZA200807547B (en) Method for producing 4-oxoquinoline compound
ITMI20061344A1 (it) Metodo per il rilascio di mercurio
EE00727U1 (et) Meetod haruldase muldmetallihendi puhtuse m„„ramiseks
IL192616A0 (en) Method for producing thiazole compound
FI20065791L (fi) Menetelmä vähäenergiaisen valmisteen rakenteen muokkaamiseksi
GB0604142D0 (en) Compound
DK1776099T3 (da) Fremgangsmåder til forbedring af biotilgængeligheden af en renininhibitor
GB0411609D0 (en) Method for determining the solubility of a chemical compound

Legal Events

Date Code Title Description
EXFP Utility model extended to 8 or 10 years after payment of fee

Expiry date: 20150427

MM1K Lapse, due to non-payment of fee

Effective date: 20150427